King County Opioid Litigation

King County v. Purdue Pharma, L.P., et al.
United States District Court for the Western District of Washington
Case No. 2:18-cv-00225

Case Overview

Keller Rohrback L.L.P., on behalf of King County, Washington, filed a lawsuit against Purdue Pharma, Endo Pharmaceuticals and Janssen Pharmaceuticals, three of the biggest manufacturers of prescription opioids in the United States, as well as other related entities and individuals responsible for the opioid epidemic. The suit was filed to hold the drug manufacturers accountable for providing false and misleading information to doctors and patients about the safety and efficacy of prescription opioid medicine over approximately the last 20 years.

The suit was filed to hold the Defendants accountable for their “reckless promotion of the use of potent opioids for chronic pain while deliberately downplaying the significant risks of the addiction and overdose.” King County is on the front line of combating the resulting opioid crisis and has suffered significant economic damages as a result.

“We are deeply honored to work with the King County Prosecutor’s office to bring this critical litigation on behalf of King County,” said Derek Loeser, a partner at Keller Rohrback. “King County has been a leader in working to end the opioid crisis. But, it’s time that the companies responsible for the epidemic be held accountable for the disaster they created. This lawsuit seeks to do just that.”

The United States is in the grip of an opioid crisis. King County, one of the largest counties in the country, has been deeply affected by this epidemic. In 2016, 219 residents died from opioid-related overdoses. From 2007 to 2016, fatal overdoses caused by opioids were the leading cause of drug-related deaths in King County.

Case Status

Keller Rohrback’s Complaint was filed on January 5, 2018, in the Superior Court of King County, Washington, and removed to the Western District of Washington on February 12, 2018. On February 26, 2018, the case was transferred into the national MDL (Multi-District Litigation) In re: National Prescription Opiate Litigation, MDL No. 2804, in the Northern District of Ohio before the Honorable Dan A. Polster.

Case Documents

Complaint – 01/05/2018

Conditional Transfer Order – 02/26/2018

 Amended Complaint – 05/25/2018

Contact Us

If you would like more information regarding this case, please contact us via email or call us at 206.623.1900.

Website Design by 3Circle Media